Linfu Zhou
- Topics
- Asthma and respiratory diseases (10 papers)IL-33, ST2, and ILC Pathways (4 papers)Immune Cell Function and Interaction (4 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Linfu Zhou
20 papers receiving 394 citations
Peers
Comparison fields: 5 of 76
- Physiology 147
- Molecular Biology 120
- Pulmonary and Respiratory Medicine 102
- Immunology 102
- Immunology and Allergy 40
Countries citing papers authored by Linfu Zhou
This map shows the geographic impact of Linfu Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linfu Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linfu Zhou more than expected).
Fields of papers citing papers by Linfu Zhou
This network shows the impact of papers produced by Linfu Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linfu Zhou. The network helps show where Linfu Zhou may publish in the future.
Co-authorship network of co-authors of Linfu Zhou
This figure shows the co-authorship network connecting the top 25 collaborators of Linfu Zhou. A scholar is included among the top collaborators of Linfu Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linfu Zhou. Linfu Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 4 | |
| 3 | 9 | |
| 4 | 6 | |
| 5 | 6 | |
| 6 | 5 | |
| 7 | 6 | |
| 8 | 40 | |
| 9 | 27 | |
| 10 | 46 | |
| 11 | [Inhibitory effects of apigenin on the expression of GATA-3 and Th2 cytokines in asthmatic mice]. | 3 |
| 12 | 6 | |
| 13 | 59 | |
| 14 | 27 | |
| 15 | 7 | |
| 16 | 61 | |
| 17 | Increased RhoGDI2 and peroxiredoxin 5 levels in asthmatic murine model of beta2-adrenoceptor desensitization: a proteomics approach. | 8 |
| 18 | 65 | |
| 19 | 1 | |
| 20 | Toll-like receptors: function and roles in asthma. | 9 |
About Linfu Zhou
Linfu Zhou is a scholar working on Physiology, Immunology and Toxicology, having authored 20 papers that have together received 398 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (10 papers), IL-33, ST2, and ILC Pathways (4 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Immunology and Allergy (40 citations), Physiology (147 citations) and Immunology (102 citations). Linfu Zhou has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Kaisheng Yin, Qian Zhang, Yin Kai-sheng, Mao Huang, Aihua Hu, Xuefan Cui, Yi Zhu, Weiping Xie, Mao Huang and Q. Du. Their work appears in journals such as PLoS ONE, European Journal of Pharmacology and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.